EDAP TMS S.A. (NASDAQ:EDAP) was upgraded by analysts at ValuEngine from a “sell” rating to a “hold” rating in a note issued to investors on Friday, October 6th.
Other equities analysts have also recently issued reports about the company. HC Wainwright set a $7.00 price objective on EDAP TMS and gave the stock a “buy” rating in a report on Wednesday, July 19th. Zacks Investment Research cut EDAP TMS from a “strong-buy” rating to a “hold” rating in a report on Monday, July 24th.
Shares of EDAP TMS (NASDAQ:EDAP) opened at 3.16 on Friday. The stock’s 50 day moving average price is $3.02 and its 200-day moving average price is $2.93. EDAP TMS has a 52 week low of $2.25 and a 52 week high of $3.85. The firm’s market capitalization is $91.63 million.
EDAP TMS (NASDAQ:EDAP) last announced its earnings results on Wednesday, August 23rd. The medical equipment provider reported ($0.05) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.03). The business had revenue of $10.40 million during the quarter, compared to the consensus estimate of $10.00 million. EDAP TMS had a positive return on equity of 10.31% and a negative net margin of 0.27%. EDAP TMS’s revenue was up 13.0% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.10 earnings per share. Equities analysts predict that EDAP TMS will post $0.01 earnings per share for the current year.
TRADEMARK VIOLATION WARNING: This news story was originally posted by BBNS and is the property of of BBNS. If you are viewing this news story on another website, it was copied illegally and republished in violation of US & international trademark and copyright laws. The correct version of this news story can be accessed at https://baseballnewssource.com/markets/edap-tms-s-a-edap-lifted-to-hold-at-valuengine/1700505.html.
Institutional investors and hedge funds have recently bought and sold shares of the company. Virtu KCG Holdings LLC purchased a new position in shares of EDAP TMS in the 2nd quarter worth about $117,000. Essex Investment Management Co. LLC purchased a new position in shares of EDAP TMS in the 2nd quarter worth about $172,000. Hilton Capital Management LLC boosted its holdings in shares of EDAP TMS by 43.1% in the 2nd quarter. Hilton Capital Management LLC now owns 83,000 shares of the medical equipment provider’s stock worth $274,000 after purchasing an additional 25,000 shares in the last quarter. Finally, Archon Capital Management LLC purchased a new position in shares of EDAP TMS in the 2nd quarter worth about $2,474,000. Hedge funds and other institutional investors own 9.41% of the company’s stock.
About EDAP TMS
EDAP TMS SA (EDAP) is a holding company engaged in developing and marketing the Ablatherm and Focal One devices. The Company operates two divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) (including lithotripsy activities). The Company is developing HIFU technology for the treatment of certain other types of tumors.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for EDAP TMS S.A. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EDAP TMS S.A. and related companies with our FREE daily email newsletter.